kevinmd.com /1 month ago

After 2 failed antidepressants, raise TMS and esketamine

In community interventional psychiatry practices, the typical referral looks the same week after week. The patient is in the fifth or sixth year of a major depressive episode and c...

Read source
kevinmd.com /3 weeks ago

TMS and esketamine work. Community clinics are the test.

For most of the past two decades, community practice has managed treatment-resistant depression (TRD) the way STAR*D described: one medication after another, with remission rates f...

Read source
budgetsavvydiva.com /1 month ago

When Depression Doesn’t Respond to Treatment: What Are Your Options?

Depression treatment doesn’t always produce the improvements people expect, even after months of medication, therapy or lifestyle changes. Some individuals experience only partial...

Read source
goodfruit.com /3 weeks ago

Resistance is possible but not proven

—Northwest organic apple growers have been finding pockets of resistance to some strains of codling moth granulosis virus, but researchers and experts are exploring other reasons w...

Read source
bioengineer.org /1 month ago

AML epigenetic therapies face network-driven resistance, review finds

A comprehensive review finds that AML cells commonly overcome epigenetic drugs through compensatory chromatin and transcriptional adaptation, favoring biomarker-selected combinatio...

Read source
kevinmd.com /2 weeks ago

TMS vs. Spravato: which to try first for depression

Most of us know the moment. A patient has failed two, sometimes three, adequate antidepressant trials, maybe an augmentation agent too. They are still depressed, often demoralized,...

Read source
phys.org /1 month ago

The right timing of treatment keeps resistant cells in check, yeast experiments suggest

The development of treatment resistance is one of the key challenges in modern cancer and antibiotic therapy. New therapeutic approaches aim to curb the spread of resistance throug...

Read source
bioengineer.org /1 month ago

Old Antabuse Drug Turns Breast Cancer Resistance Against Itself

Chemotherapy has long been a workhorse against metastatic breast cancer, yet for most patients with estrogen receptor-positive (ER+) disease, the cancer eventually wins the evoluti...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.